These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19761728)

  • 1. Minimal-change nephrotic syndrome due to occupational mercury vapor inhalation.
    Campbell G; Leitch D; Lewington A; Dargan PI; Baker RJ
    Clin Nephrol; 2009 Sep; 72(3):216-9. PubMed ID: 19761728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on "Minimal change nephrotic syndrome due to occupational mercury vapor inhalation".
    Al Habbal MJ
    Clin Nephrol; 2010 Aug; 74(2):166; author reply 166. PubMed ID: 20630141
    [No Abstract]   [Full Text] [Related]  

  • 3. Mercury-induced nephrotic syndrome: a case report and review of the literature.
    Wągrowska-Danilewicz M; Danilewicz M; Zbrog Z
    Pol J Pathol; 2014 Dec; 65(4):322-6. PubMed ID: 25693087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotic syndrome of minimal change disease following exposure to mercury-containing skin lightening cream: A case report and literature review.
    Gao H; Liu G; He Y; Chen J
    Clin Nephrol; 2022 Aug; 98(2):107-112. PubMed ID: 35603688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal change disease following exposure to mercury-containing skin lightening cream.
    Tang HL; Chu KH; Mak YF; Lee W; Cheuk A; Yim KF; Fung KS; Chan HW; Tong KL
    Hong Kong Med J; 2006 Aug; 12(4):316-8. PubMed ID: 16912361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features, diagnosis, and treatment of IgA nephropathy with minimal change disease related to exposure to mercury-containing cosmetics: a case report
.
    Niu HX; Li SH; Li HY; Chen YH; Liu WW; Li PL; Long HB
    Clin Nephrol; 2017 Apr; 87 (2017)(4):196-201. PubMed ID: 28102816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipoid nephrosis of toxic origin. 2 cases].
    Belghiti D; Patey O; Berry JP; Antelin C; Hirbec G; Lagrue G
    Presse Med; 1986 Nov; 15(39):1953-5. PubMed ID: 2947217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.
    Van der Linde AA; Pillen S; Gerrits GP; Bouwes Bavinck JN
    Clin Toxicol (Phila); 2008 Jun; 46(5):479-81. PubMed ID: 18568806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal change disease caused by exposure to mercury-containing skin lightening cream: a report of 4 cases.
    Tang HL; Mak YF; Chu KH; Lee W; Fung SK; Chan TY; Tong KL
    Clin Nephrol; 2013 Apr; 79(4):326-9. PubMed ID: 23537684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute pneumonitis caused by inhalation of mercury vapor--report of a case].
    Lin TC; Gue ZW; Hwang MS
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Feb; 43(2):141-6. PubMed ID: 2766070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotic syndrome of minimal change disease following exposure to mercury-containing skin-lightening cream.
    Zhang L; Liu F; Peng Y; Sun L; Chen C
    Ann Saudi Med; 2014; 34(3):257-61. PubMed ID: 25266189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mercury poisoning from home gold amalgam extraction.
    Saleem M; Alfred S; Bahnisch RA; Coates P; Kearney DJ
    Med J Aust; 2013 Jul; 199(2):125-7. PubMed ID: 23879513
    [No Abstract]   [Full Text] [Related]  

  • 13. Membranous glomerulonephritis associated with industrial mercury exposure. Study of pathogenetic mechanisms.
    Tubbs RR; Gephardt GN; McMahon JT; Pohl MC; Vidt DG; Barenberg SA; Valenzuela R
    Am J Clin Pathol; 1982 Apr; 77(4):409-13. PubMed ID: 7041618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: severe mercuric sulphate poisoning treated with 2,3-dimercaptopropane-1-sulphonate and haemodiafiltration.
    Dargan PI; Giles LJ; Wallace CI; House IM; Thomson AH; Beale RJ; Jones AL
    Crit Care; 2003 Jun; 7(3):R1-6. PubMed ID: 12793883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intention and action myoclonus disclosing occupational mercury poisoning].
    Roullet E; Nizou R; Jedynak P; Lhermitte F
    Rev Neurol (Paris); 1984; 140(1):55-8. PubMed ID: 6695124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microenvironmental exposure to mercury vapor.
    Stopford W; Bundy SD; Goldwater LJ; Bittikofer JA
    Am Ind Hyg Assoc J; 1978 May; 39(5):378-84. PubMed ID: 677017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotic syndrome in two members of a family with mercury poisoning.
    Meeks A; Keith PR; Tanner MS
    J Trace Elem Electrolytes Health Dis; 1990 Dec; 4(4):237-9. PubMed ID: 2136288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cell mediated immunity in a mercury nephrotic syndrome (author's transl)].
    Normand M; Cayotte JL; Chouraqui D; Fizet D
    Sem Hop; 1982 May; 58(19):1185-7. PubMed ID: 6285502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disorders of liver function in occupational chronic lead and mercury vapor poisoning].
    Kośmider S; Potocka Z
    Zentralbl Arbeitsmed; 1967 Jun; 17(6):170-4. PubMed ID: 5616271
    [No Abstract]   [Full Text] [Related]  

  • 20. Health effects associated with long-term occupational exposure of employees of a chlor-alkali plant to mercury.
    Neghab M; Norouzi MA; Choobineh A; Kardaniyan MR; Zadeh JH
    Int J Occup Saf Ergon; 2012; 18(1):97-106. PubMed ID: 22429533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.